Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

被引:67
|
作者
Ebeling, PR [1 ]
Erbas, B
Hopper, JL
Wark, JD
Rubinfeld, AR
机构
[1] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Bone & Mineral Serv, Melbourne, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Publ Hlth & Community Med, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Thorac Med, Melbourne, Vic 3050, Australia
关键词
D O I
10.1359/jbmr.1998.13.8.1283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inhaled glucocorticoids are pivotal in maintenance therapy of chronic bronchial asthma; however, conflict exists over their effects on bone and mineral metabolism. We measured bone mineral density (BMD), bone turnover markers, and adrenal steroid hormones in 53 patients (34 female, 19 male) with chronic bronchial asthma who had taken either inhaled beclomethasone or budesonide in doses of greater than or equal to 1500 mu g/day for at least 12 months to determine pathogenetic mechanisms of bone loss. To account for the effect of prior oral glucocorticoid exposure we divided patients into two groups: one with (OG) and the other without (IG) a past history of maintenance (> 1 month) oral glucocorticoid therapy. Lumbar spine (LS) and proximal femur BMDs were similar to 1 SD lower in men and women taking OG or high-dose IG for chronic bronchial asthma, potentially equivalent to a doubling of the risk of fracture at these sites. Prior exposure to OG in women was also associated with lower LS and proximal femur BMDs, while men were more sensitive to the adverse effects of IG on LS and Ward's triangle BMDs, Bone formation markers were decreased; however, bone resorption marker concentrations were normal. All patients had evidence of suppression of both endogenous glucocorticoid and adrenal androgen production. Both total duration of OG and biochemical bone turnover marker concentrations were negatively related to proximal femur and rib BMDs and total body bone mineral content, but not to LS BMD, These were stronger for bone resorption markers. Uncoupling of ongoing normal bone resorption from suppressed bone formation may therefore contribute to glucocorticoid-associated bone loss in asthma, Adrenal androgen suppression may also increase the susceptibility of postmenopausal women in particular to bone loss with OG, Although the effects of high-dose IG on BMD are associated with lower LS BMD in men, this observation should now be investigated further in prospective studies.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [41] LONG-TERM THYROXINE TREATMENT AND BONE-MINERAL DENSITY
    FRANKLYN, JA
    BETTERIDGE, J
    DAYKIN, J
    HOLDER, R
    OATES, GD
    PARLE, JV
    LILLEY, J
    HEATH, DA
    SHEPPARD, MC
    LANCET, 1992, 340 (8810): : 9 - 13
  • [42] Psoriasis and bone mineral density: Implications for long-term patients
    D'Epiro, Sara
    Marocco, Chiara
    Salvi, Monica
    Mattozzi, Carlo
    Luci, Cecilia
    Macaluso, Laura
    Giancristoforo, Simona
    Campoli, Marco
    Scarno, Marco
    Migliaccio, Silvia
    Calvieri, Stefano
    Richetta, Antonio
    JOURNAL OF DERMATOLOGY, 2014, 41 (09): : 783 - 787
  • [43] Bone mineral density in long-term survivors of childhood cancer
    Arikoski, P
    Voutilainen, R
    Kröger, H
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 : 343 - 353
  • [44] Bone mineral density in patients on long-term orlistat treatment
    Giorgadze, E.
    Tsagareli, M.
    Asatiani, K.
    Bochorishvili, K.
    Tsagareli, N.
    Bestavashvili, L.
    Sulikashvili, T.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S39 - S39
  • [45] Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
    Sawamura, Masato
    Komatsuda, Atsushi
    Togashi, Masaru
    Wakui, Hideki
    Takahashi, Naoto
    INTERNAL MEDICINE, 2017, 56 (06) : 631 - 636
  • [46] Bone mineral density in children with asthma treated with inhaled corticosteroids
    Nowacka, K
    Lorenc, RS
    Matusik, H
    Taajko, A
    PAEDIATRIC OSTEOLOGY: PREVENTION OF OSTEOPOROSIS - A PAEDIATRIC TASK?, 1998, 1154 : 167 - 171
  • [47] Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly
    Calatayud, Maria
    Perez-Olivares Martin, Laura
    Soledad Librizzi, Maria
    Lora Pablos, David
    Gonzalez Mendez, Violeta
    Aramendi Ramos, Mercedes
    Martinez Diaz-Guerra, Guillermo
    Hawkins, Federico
    CLINICAL ENDOCRINOLOGY, 2021, 95 (01) : 58 - 64
  • [48] THE CORRELATION BETWEEN LONG-TERM USE OF ORAL FUROSEMIDE AND BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN
    Duraj, V.
    Kollcaku, A.
    Hankollari, J.
    Bodinaku, J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S226 - S226
  • [49] Bone Mineral Density in women with asthma on long term Inhaled Corticosteroid therapy.
    Reddy, BM
    Vilar, MB
    Silverman, BA
    Bassett, CW
    Rao, YAK
    Schneider, AT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S229 - S229
  • [50] Continuity study of the bone mineral density reduction in long term use of inhaled corticosteroids
    Stojanovski, Zoran
    Nicevski, Trajce
    Minov, Jordan
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46